The California Stem Cell Report

Correction on Platform Technology Item on Jan. 16

David Jensen's avatar
David Jensen
Jan 29, 2026
∙ Paid

The platform technology item on Jan. 16 incorrectly said that CIRM has had conversations with the FDA concerning its RAPID platform technology. In fact, the reference to the FDA applied to a different effort.

“CIRM has not had conversations with the FDA regarding a specific platform strategy,” the agency said in an email.

User's avatar

Continue reading this post for free, courtesy of David Jensen.

Or purchase a paid subscription.
© 2026 David Jensen · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture